Literature DB >> 308954

Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.

J Donofrio, M S Coleman, J J Hutton, A Daoud, B Lampkin, J Dyminski.   

Abstract

The deoxynucleotide, dATP, is elevated 50- to 1,000-fold above normal in erythrocytes, lymphocytes, and bone marrow from a child with adenosine deaminase deficiency and severe combined immunodeficiency disease. The child, when 17 mo of age, was also excreting approximately 30 mg of deoxyadenosine per day in urine (normal is less than 0.1 mg/day). Urinary excretion of uric acid was decreased. Elevated dATP levels in lymphocytes and bone marrow, and increased urinary excretion of deoxyadenosine, persisted despite hypertransfusion of the child with irradiated erythrocytes from a donor with normal adenosine deaminase. Overproduction of deoxynucleotides by increased salvage of adenosine appears to be the primary metabolic abnormality in patients with adenosine de aminase deficiency.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308954      PMCID: PMC371841          DOI: 10.1172/JCI109201

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  9 in total

1.  Enzymatic synthesis of deoxyribonucleic acid. IX. The polymerase formed after T2 bacteriophage infection of Escherichia coli: a new enzyme.

Authors:  H V APOSHIAN; A KORNBERG
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

2.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

3.  DNA polymerases in normal and leukemic human hematopoietic cells.

Authors:  M S Coleman; J J Hutton; F J Bollum
Journal:  Blood       Date:  1974-07       Impact factor: 22.113

4.  A rapid quantitative determination of deoxyribonucleoside triphosphates based on the enzymatic synthesis of DNA.

Authors:  A W Solter; R E Handschumacher
Journal:  Biochim Biophys Acta       Date:  1969-02-18

5.  Identification and quantitation of adenine deoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  M S Coleman; J Donofrio; J J Hutton; L Hahn; A Daoud; B Lampkin; J Dyminski
Journal:  J Biol Chem       Date:  1978-03-10       Impact factor: 5.157

Review 6.  Enzymatic reduction of ribonucleotides: biosynthesis pathway of deoxyribonucleotides.

Authors:  H Follmann
Journal:  Angew Chem Int Ed Engl       Date:  1974-09       Impact factor: 15.336

7.  A sensitive method for the determination of RNA in DNA and vice versa.

Authors:  D S Duch; M Laskowski
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

8.  Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  S H Polmar; R C Stern; A L Schwartz; E M Wetzler; P A Chase; R Hirschhorn
Journal:  N Engl J Med       Date:  1976-12-09       Impact factor: 91.245

9.  Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.

Authors:  A Cohen; R Hirschhorn; S D Horowitz; A Rubinstein; S H Polmar; R Hong; D W Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

  9 in total
  51 in total

1.  The rate of the AMP/adenosine substrate cycle in concanavalin-A-stimulated rat lymphocytes.

Authors:  Z Szondy; E A Newsholme
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

2.  Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.

Authors:  S Seto; C J Carrera; M Kubota; D B Wasson; D A Carson
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

3.  Sodium-calcium exchange in the outer segments of bovine rod photoreceptors.

Authors:  P P Schnetkamp
Journal:  J Physiol       Date:  1986-04       Impact factor: 5.182

4.  In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.

Authors:  M S Hershfield; N M Kredich; D R Ownby; H Ownby; R Buckley
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

5.  Biochemical basis for the enhanced toxicity of deoxyribonucleosides toward malignant human T cell lines.

Authors:  D A Carson; J Kaye; S Matsumoto; J E Seegmiller; L Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

6.  Immune deficiency due to adenosine deaminase and purine nucleoside phosphorylase deficiency: a simple diagnostic test.

Authors:  J L Maddocks; S A Al-Safi; G Wilson
Journal:  J Clin Pathol       Date:  1984-11       Impact factor: 3.411

7.  Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation.

Authors:  S H Chen; H D Ochs; C R Scott; E R Giblett; A J Tingle
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

8.  Increased ascorbic acid content in chronic lymphocytic leukemia B lymphocytes.

Authors:  L Liebes; R Krigel; S Kuo; D Nevrla; E Pelle; R Silber
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.

Authors:  M S Hershfield; N M Kredich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

10.  Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency.

Authors:  K C Rich; C M Richman; E Mejias; P Daddona
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.